Metre.ai is a health technology startup that focuses on providing personalized biometric feedback through innovative breath analysis. The company operates in the health and wellness market, targeting individuals who are keen on managing their metabolic health, including those dealing with Type 2 Diabetes (T2D), weight loss, and general metabolic health concerns.

Metre.ai's flagship product, MetreAce, is a breath acetone measurement device that offers a painless, non-invasive, and cost-effective alternative to traditional finger-prick blood tests. By measuring ketone levels in the breath, MetreAce provides users with real-time, actionable data on their metabolic state. This allows individuals to understand their unique metabolic responses to different foods and make informed decisions about their diet and lifestyle.

The company serves a diverse clientele, including health-conscious individuals, people on ketogenic diets, and those managing chronic conditions like T2D. Metre.ai's technology is built on proven, patent-protected breath testing devices, and it leverages proprietary algorithms to ensure the accuracy and reliability of the data provided.

Metre.ai's business model revolves around the sale of its MetreAce device and the accompanying iOS app, which enhances the user experience by seamlessly integrating with the device. The app provides users with detailed insights and personalized feedback, helping them track their progress and make necessary adjustments to their diet and exercise routines.

Revenue is generated primarily through the direct sale of the MetreAce device and potential subscription services for advanced features and continuous updates via the app. By offering a unique and user-friendly solution, Metre.ai aims to empower individuals to take control of their health and make data-driven decisions.

Keywords: Metabolic Health, Ketone Measurement, Breath Analysis, Non-Invasive, Personalized Feedback, Type 2 Diabetes, Weight Loss, Ketogenic Diet, Health Technology, Biometric Data.